Walensky, Fauci, and Kessler to Testify on Vaccination Progress and Need for Continued Measures to Defeat Virus

Apr 7, 2021
Press Release

Washington, D.C. (April 7, 2021)—On Thursday, April 15, 2021, at 10:00 a.m. ET, Rep. James E. Clyburn, the Chairman of the Select Subcommittee on the Coronavirus Crisis, will hold a hybrid in-person / remote hearing with Centers for Disease Control and Prevention Director Rochelle P. Walensky, National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci, and Chief Science Officer for COVID Response David Kessler.

The hearing will examine the Biden Administration's progress in accelerating vaccine access nationwide and the crucial importance of adhering to public health measures like masks and distancing to save lives and slow the spread of dangerous virus variants in the weeks and months before all can be fully vaccinated.

The hearing follows a record-breaking weekend for vaccinations, with CDC reporting more than four million people receiving doses on Saturday, April 3, the nation’s highest one-day total since the vaccine rollout began.  Nevertheless, CDC Director Walensky warned Monday of “continued concerning data trends” in coronavirus cases and deaths among those who have yet to receive a vaccine.

Breaking from the previous Administration’s failed approach, the Biden-Harris Administration has taken a science-based approach to ending the pandemic.  President Biden recently announced a $10 billion investment in vaccine equity.



Hybrid hearing on "Reaching the Light at the End of the Tunnel: A Science-Driven Approach to Swiftly and Safely Ending the Pandemic"


Thursday, April 15, 2021, at 10:00 a.m. ET



Rochelle P. Walensky, MD, MPH

Director, Centers for Disease Control and Prevention


Anthony S. Fauci, MD

Director, National Institute of Allergy and Infectious Diseases

National Institutes of Health


David Kessler, MD

Chief Science Officer, COVID Response

Department of Health and Human Services



A livestream will be available on YouTube and the Select Subcommittee website.



117th Congress